Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Invesco S&P 500 Equal Weight Health Care ETF (NY:RSPH)

39.46 +0.02 (+0.05%)
Official Closing Price Updated: 8:00 PM EDT, Oct 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Invesco S&P 500 Equal Weight Health Care ETF

News headline image
Which Healthcare ETF Is the Better Buy: Invesco’s Broad RSPH or First Trust’s Biotech FBT? ↗
FBT has outperformed RSPH by a wide margin recently. The question is whether you want to own the fund that won last year or the one built to hold up over many years. 
Via The Motley Fool
Topics ETFs
News headline image
Invesco’s RSPH or iShares’ IBB: Which Healthcare ETF Is the Better Long-Term Buy? ↗
RSPH offers broader healthcare exposure with lower volatility and higher dividend yield, while IBB provides concentrated biotech focus with stronger recent returns. 
Via The Motley Fool
Topics ETFs
News headline image
VanEck Biotech vs. Invesco Healthcare: Which ETF Offers More Potential for Long-Term Growth? ↗
These two healthcare ETFs offer investors exposure to some of medicine's biggest names, but their different approaches to investing could lead to very different results. 
Via The Motley Fool
Topics ETFs
News headline image
Better Invesco Healthcare ETF: PJP Targeting Pharmaceuticals vs. RSPH's Broader Sector Lens ↗
PJP's one-year return beats RSPH's, but RSPH offers broader diversification across 61 healthcare holdings at a lower expense ratio. 
Via The Motley Fool
Topics ETFs
News headline image
PBE vs. RSPH: Is a Biotech ETF or Equal-Weight Healthcare ETF the Better Choice for Investors? ↗
PBE offers higher income and stronger returns, while RSPH provides broader diversification with lower costs and drawdown risk. 
Via The Motley Fool
Topics ETFs
News headline image
Should You Bet Big on Drugmakers? VanEck Pharmaceutical ETF vs. Invesco Healthcare ETF Compared. ↗
PPH offers concentrated pharma exposure with 1.9% yield and lower volatility, while RSPH provides broader diversification across 60 healthcare holdings. 
Via The Motley Fool
Topics ETFs
News headline image
Does iShares Pharma ETF Offer Superior Returns to Invesco's Equal Weight Healthcare Fund? ↗
IHE's concentrated pharma holdings delivered 50% returns over one year, while RSPH's equal-weight healthcare approach generated 29%. Risk profiles differ sharply too. 
Via The Motley Fool
Topics ETFs
News headline image
This Healthcare ETF Is Outperforming the Invesco Equal Weight Fund -- and It Offers a Charitable Twist ↗
Active management and concentrated bets drove a 42% one-year return, though the lower-cost Invesco alternative offers broader diversification across 60 healthcare stocks. 
Via The Motley Fool
Topics ETFs
News headline image
Which Is the Better Invesco Healthcare ETF: Equal-Weight RSPH or Biotech-Focused IBBQ? ↗
RSPH levels the playing field across 60 established healthcare names while IBBQ bets on more than 250 biotech companies at a lower cost. 
Via The Motley Fool
Topics ETFs
News headline image
Better Healthcare ETF: State Street's Pharmaceuticals-Focused XPH vs. Invesco's S&P 500-Targeted RSPH ↗
One fund targets pharma exclusively and surged 63% in a year, while the other diversifies across healthcare with lower volatility. 
Via The Motley Fool
Topics ETFs Stocks
News headline image
Which Healthcare ETF Is the Better Buy: Fidelity's FHLC or Invesco's Equal-Weight RSPH? ↗
FHLC's 0.08% expense ratio and market-cap approach delivered stronger returns, while RSPH's equal-weight strategy offers lower volatility and broader diversification across 60 holdings. 
Via The Motley Fool
Topics ETFs
News headline image
IXJ vs. RSPH: Which Healthcare ETF Is the Better Buy? ↗
IXJ offers a higher dividend yield and lower volatility with global exposure, while RSPH's equal-weight approach posted a stronger 1-year return. 
Via The Motley Fool
Topics ETFs
News headline image
Healthcare Investing in 2026: iShares Global Healthcare ETF Outperforms Invesco Health Care ETF ↗
IXJ's market-cap weighting and international exposure delivered stronger five-year returns and lower volatility, while offering double the dividend yield. 
Via The Motley Fool
Topics ETFs
News headline image
Invesco Healthcare ETF vs VanEck Biotech: Which ETF Will Deliver the Healthiest Returns for 2026? ↗
RSPH offers 60 diversified holdings with lower volatility, while BBH concentrates on 25 biotech leaders with stronger recent returns. 
Via The Motley Fool
Topics ETFs
News headline image
Invesco's RSPH vs. PJP: Which Health Care ETF Is the Better Fund For The GLP-1 Revolution? ↗
Compare portfolio strategies, cost structures, and risk profiles as two Invesco healthcare ETFs take different paths to sector exposure. 
Via The Motley Fool
Topics ETFs
News headline image
State Street's Health Care ETF Tops Invesco's on Yield and Returns ↗
Expense ratios, dividend yields, and risk profiles set these healthcare ETFs apart. See how their strategies shape long-term performance for investors. 
Via The Motley Fool
Topics ETFs
News headline image
Apple, Western Union, Palo Alto And More On CNBC's 'Final Trades' ↗
Apple, Palo Alto and Western Union are among the companies mentioned on the latest edition of CNBC's "Final Trades." 
Via Benzinga
News headline image
Tesla And Amazon Just Became A Problem For The Entire Discretionary Sector ↗
The consumer discretionary sector is underperforming due to stock concentration in Tesla and Amazon, but smaller companies in the sector are quietly delivering steady gains. 
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.